Publications by authors named "Clemence Perret"

Claim this Profile
A
A Chemically Defined TLR3 Agonist with Anticancer Activity.
Julie Le Naour, Sylvain Thierry, Sarah Adriana Scuderi, Mathilde Boucard-Jourdin, Peng Liu, Clémence Perret

Oncoimmunology· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization.
Sylvain Thierry, Sarah Maadadi, Aurore Berton, Laura Dimier, Clémence Perret

Microb Cell· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis